These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Significant relationship between serum high-sensitivity C-reactive protein, high-density lipoprotein cholesterol levels and children with Kawasaki disease and coronary artery lesions. Ou CY; Tseng YF; Lee CL; Chiou YH; Hsieh KS J Formos Med Assoc; 2009 Sep; 108(9):719-24. PubMed ID: 19773210 [TBL] [Abstract][Full Text] [Related]
8. Serum cholesterol levels during and after Kawasaki disease. Salo E; Pesonen E; Viikari J J Pediatr; 1991 Oct; 119(4):557-61. PubMed ID: 1919886 [TBL] [Abstract][Full Text] [Related]
9. Serum lipids in north Indian children treated for kawasaki disease. Mitra A; Singh S; Devidayal ; Khullar M Int Heart J; 2005 Sep; 46(5):811-7. PubMed ID: 16272772 [TBL] [Abstract][Full Text] [Related]
10. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. Tse SM; Silverman ED; McCrindle BW; Yeung RS J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960 [TBL] [Abstract][Full Text] [Related]
11. Chemokines in Kawasaki disease: measurement of CCL2, CCL22 and CXCL10. Shikishima Y; Saeki T; Matsuura N Asian Pac J Allergy Immunol; 2003 Sep; 21(3):139-43. PubMed ID: 15032397 [TBL] [Abstract][Full Text] [Related]
12. Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease. Lee KY; Han JW; Lee JS; Whang KT Acta Paediatr; 2002; 91(2):164-7. PubMed ID: 11952003 [TBL] [Abstract][Full Text] [Related]
13. Serum M-CSF levels in Kawasaki disease. Oana S; Terai M; Kohno Y Br J Haematol; 1999 Nov; 107(2):462-3. PubMed ID: 10583242 [No Abstract] [Full Text] [Related]
14. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease. Conran N; Saad ST; Costa FF; Ikuta T Ann Hematol; 2007 Apr; 86(4):255-61. PubMed ID: 17205286 [TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Cabana VG; Gidding SS; Getz GS; Chapman J; Shulman ST Pediatr Res; 1997 Nov; 42(5):651-5. PubMed ID: 9357939 [TBL] [Abstract][Full Text] [Related]
16. Studies of peripheral blood toxic neutrophils as a predictor of coronary risk in Kawasaki disease--the pathogenetic role of hematopoietic colony-stimulating factors (GM-CSF, G-CSF). Takeshita S; Sekine I; Fujisawa T; Yoshioka S Acta Paediatr Jpn; 1990 Oct; 32(5):508-14. PubMed ID: 1704677 [TBL] [Abstract][Full Text] [Related]